Search research articles
Contact Us
Filters
Showing results (21-30 of 68) with videos related to
Page
of 7
Sort By:
ESMO Open
|
August 20, 2019
Cancer medicines in Asia and Asia-Pacific: What is available, and is it effective enough?
Alexandru Eniu, Nathan I Cherny, Melanie Bertram, et al.
JCO Oncology Practice
|
February 25, 2026
Imposter Syndrome, Burnout, and Maladaptive Perfectionism Among Oncology Professionals: A Global Cross-Sectional Study
Enes Erul, Vilma Pacheco-Barcia, Ali Alkan, et al.
Plos One
|
July 29, 2014
Differential peripheral blood gene expression profile based on Her2 expression on primary tumors of breast cancer patients
Oana Tudoran, Oana Virtic, Loredana Balacescu, et al.
Critical Reviews in Oncology/Hematology
|
March 20, 2021
Live European School of Oncology e-Sessions (e-ESO)
Marco Siano, Francesca Marangoni, Nicholas Pavlidis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 11, 2017
Long-term efficacy analysis of the randomised, phase II TRYPHAENA cardiac safety study: Evaluating pertuzumab and trastuzumab plus standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer
Andreas Schneeweiss, Stephen Chia, Tamas Hickish, et al.
Cancer
|
October 7, 2008
Breast pathology guideline implementation in low- and middle-income countries
Shahla Masood, László Vass, Julio A Ibarra, et al.
International Journal of Clinical and Experimental Medicine
|
August 27, 2015
Clinical implications of multifocality as a prognostic factor in breast carcinoma - a multivariate analysis study comprising 460 cases
Monica Boros, Septimiu Voidazan, Cosmin Moldovan, et al.
Cancer
|
October 7, 2008
Guideline implementation for breast healthcare in low- and middle-income countries: treatment resource allocation
Alexandru Eniu, Robert W Carlson, Nagi S El Saghir, et al.
JMIR Cancer
|
April 4, 2024
Comparison of the Real-World Reporting of Symptoms and Well-Being for the HER2-Directed Trastuzumab Biosimilar Ogivri With Registry Data for Herceptin in the Treatment of Breast Cancer: Prospective Observational Study (OGIPRO) of Electronic Patient-Reported Outcomes
Andreas Trojan, Sven Roth, Ziad Atassi, et al.
Journal of Global Oncology
|
September 23, 2018
Facing the Global Challenges of Access to Cancer Medication
Abdul Raman Jazieh, Abdulaziz H Al-Saggabi, Mark McClung, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 68) with videos related to
Sort By:
Page
of 7
ESMO Open
|
August 20, 2019
Cancer medicines in Asia and Asia-Pacific: What is available, and is it effective enough?
Alexandru Eniu, Nathan I Cherny, Melanie Bertram, et al.
JCO Oncology Practice
|
February 25, 2026
Imposter Syndrome, Burnout, and Maladaptive Perfectionism Among Oncology Professionals: A Global Cross-Sectional Study
Enes Erul, Vilma Pacheco-Barcia, Ali Alkan, et al.
Plos One
|
July 29, 2014
Differential peripheral blood gene expression profile based on Her2 expression on primary tumors of breast cancer patients
Oana Tudoran, Oana Virtic, Loredana Balacescu, et al.
Critical Reviews in Oncology/Hematology
|
March 20, 2021
Live European School of Oncology e-Sessions (e-ESO)
Marco Siano, Francesca Marangoni, Nicholas Pavlidis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 11, 2017
Long-term efficacy analysis of the randomised, phase II TRYPHAENA cardiac safety study: Evaluating pertuzumab and trastuzumab plus standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer
Andreas Schneeweiss, Stephen Chia, Tamas Hickish, et al.
Cancer
|
October 7, 2008
Breast pathology guideline implementation in low- and middle-income countries
Shahla Masood, László Vass, Julio A Ibarra, et al.
International Journal of Clinical and Experimental Medicine
|
August 27, 2015
Clinical implications of multifocality as a prognostic factor in breast carcinoma - a multivariate analysis study comprising 460 cases
Monica Boros, Septimiu Voidazan, Cosmin Moldovan, et al.
Cancer
|
October 7, 2008
Guideline implementation for breast healthcare in low- and middle-income countries: treatment resource allocation
Alexandru Eniu, Robert W Carlson, Nagi S El Saghir, et al.
JMIR Cancer
|
April 4, 2024
Comparison of the Real-World Reporting of Symptoms and Well-Being for the HER2-Directed Trastuzumab Biosimilar Ogivri With Registry Data for Herceptin in the Treatment of Breast Cancer: Prospective Observational Study (OGIPRO) of Electronic Patient-Reported Outcomes
Andreas Trojan, Sven Roth, Ziad Atassi, et al.
Journal of Global Oncology
|
September 23, 2018
Facing the Global Challenges of Access to Cancer Medication
Abdul Raman Jazieh, Abdulaziz H Al-Saggabi, Mark McClung, et al.
Page
of 7